Remove 2016 Remove Hospitals Remove Labelling
article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

The 2016 World Health Organization classification of MCL recognizes 2 molecular subtypes that reflect divergent pathogenesis and clinical behavior 2 : Classical MCL is derived from naive B cells that lack somatic hypermutation in IGHV , do not transit through the germinal center, and express the SOX11 transcription factor.

FDA
article thumbnail

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Pharmacy Times

Relapse risk factors include prior hospitalizations, long illness duration, and antipsychotic polypharmacy, emphasizing the need for effective maintenance treatments. Maintaining stability in schizophrenia is a major clinical challenge—each relapse can disrupt functioning, burden caregivers, and elevate hospitalization risk.

FDA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could Ozempic prevent heart attack and stroke?

The Checkup by Singlecare

Ozempic has also shown promise as a weight-loss medication and is often prescribed off-label for this purpose. For example, the 2016 SUSTAIN-6 trial tested the cardiovascular safety of semaglutide in patients with Type 2 diabetes who had established cardiovascular diseases or were at high risk.

FDA
article thumbnail

J&J eyes prostate cancer label expansion for Akeega

Pharmaceutical Technology

J&J gained prostate cancer rights for Zejula from Tesaro in 2016, the latter company was acquired by GSK. Akeega combines the active ingredients in GSK’s PARP inhibitor Zejula (niraparib) and J&J’s androgen blocker Zytiga (abiraterone). Give your business an edge with our leading industry insights.

article thumbnail

Top 10 Journal Articles To Read During Your Infectious Diseases Pharmacy Rotation

IDStewardship

It’s from 2016 about the future of antibiotics and resistance, but it remains highly relevant today and people consistently give positive feedback about it. ” Labeling the use of an antibiotic as inappropriate or appropriate cannot simply be done based upon whether it is FDA-approved for a given indication.

article thumbnail

Could acoziborole eliminate sleeping sickness in Africa?

European Pharmaceutical Review

Between 2016 and 2019, DNDi and its partners led an open-label, Phase II/III study to assess the safety and efficacy of acoziborole in patients with early- and late-stage g-HAT. 208 patients were recruited at 10 hospitals in the Democratic Republic of the Congo (DRC) and Guinea. About the Phase II/III study.

article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

The Centers for Disease Control and Prevention (CDC) estimated in 2016 that one in every 20 American children was on stimulant medication for ADHD. The manufacturer lists cocaine dependence as an off-label use. It can negatively affect children’s academic performance, behavior, and social skills.